NEULAND LABORATORIES LTD. - 524558 - Un-Audited Financial Results (Consolidated & Standalone)For The Quarter Ended June 30, 2019
Un-audited financial results (Consolidated & standalone)for the quarter ended June 30, 201913-08-2019
13-08-2019
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Meeting Updates
Results Release and Earnings Call Notice under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements), 201508-08-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation under Regulation 30(4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-08-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication dated July 17, 201917-07-2019
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for To Consider And Approve The In-Audited Financial Results For The Quarter Ended June 30, 2019
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve To consider and approve the in-audited financial results for the quarter ended June 30, 201916-07-2019
NEULAND LABORATORIES LTD. - 524558 - Shareholding for the Period Ended June 30, 2019
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here15-07-2019
NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants),Regulations, 201810-07-2019
Neuland Laboratories Ltd - 524558 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer08-07-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Analyst Meet on July 5, 201905-07-2019
NEULAND LABORATORIES LTD. - 524558 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here05-07-2019